With the recent pandemic highlighting the need for rapid drug discovery, AI has become an area of increased interest. This is driven by the ability to use machine and deep learning to discover new drugs with a speed and scale previously unheard of within the industry. But the current challenges of applying this technology within the drug discovery industry include the significant time consumption and expenses involved. This conference will discuss the solutions to these problems with presentations and updates from leading industry experts.

Join Dr Neil Thompson, Healx’s Chief Scientific Officer, as he discusses how Healx is using AI to overcome the traditional barriers to treatment development for rare diseases.

We’re looking forward to what’s set to be an insightful session. Will we see you there? If you aren’t attending but would like to learn more about our work, please contact us for more information.